Tuesday, November 5, 2019

Viking Therapeutics EPS beats by $0.05

Viking Therapeutics (NASDAQ:VKTX): Q3 GAAP EPS of -$0.08 beats by $0.05.
Cash, equivalents and short-term investments of $288.1M.
Shares -0.15% PM.
Press Release
at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.